Indication
For treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) 2 months of age and older.
Medicine details
- Medicine name:
- maralixibat (Livmarli)
- SMC ID:
- SMC2672
- Pharmaceutical company
- Mirum Pharmaceuticals
- BNF chapter
- Nutrition and blood
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- 01 July 2024